The clinical application of metabolic therapy for cardiovascular disease

Anthony Hadj, Salvatore Pepe, Franklin Lawrence Rosenfeldt

Research output: Contribution to journalArticleResearchpeer-review

12 Citations (Scopus)

Abstract

Metabolic therapy involves the administration of a substance normally found in the body to enhance a metabolic reaction within the cell. This may be achieved in two ways. Firstly, for some systems a substance can be given to achieve greater than normal levels in the body so as to drive an enzymic reaction in a preferred direction. Secondly, metabolic therapy may be used to correct an absolute or relative deficiency of a cellular component. Thus, metabolic therapy differs greatly from most standard cardiovascular pharmacologic therapies such as the use of ACE Inhibitors, beta-blockers, statins and calcium channel antagonists that are given to block rather than enhance cellular processes.
Original languageEnglish
Pages (from-to)56 - 64
Number of pages9
JournalHeart Lung and Circulation
Volume16
Issue numberSupplement 3
Publication statusPublished - 2007

Cite this

Hadj, A., Pepe, S., & Rosenfeldt, F. L. (2007). The clinical application of metabolic therapy for cardiovascular disease. Heart Lung and Circulation, 16(Supplement 3), 56 - 64.